John S Kovach - Net Worth and Insider Trading
John S Kovach Net Worth
The estimated net worth of John S Kovach is at least $257,472 dollars as of 2024-11-10. John S Kovach is the President and CEO, 10% Owner of Lixte Biotechnology Holdings Inc and owns about 154,018 shares of Lixte Biotechnology Holdings Inc (LIXT) stock worth over $257,472. Details can be seen in John S Kovach's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John S Kovach has not made any transactions after 2020-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John S Kovach
John S Kovach Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John S Kovach owns 1 companies in total, including Lixte Biotechnology Holdings Inc (LIXT) .
Click here to see the complete history of John S Kovach’s form 4 insider trades.
Insider Ownership Summary of John S Kovach
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LIXT | Lixte Biotechnology Holdings Inc | 2020-11-30 | director & 10 percent owner & Pres. & CFO & Secty |
John S Kovach Latest Holdings Summary
John S Kovach currently owns a total of 1 stock. John S Kovach owns 154,018 shares of Lixte Biotechnology Holdings Inc (LIXT) as of November 30, 2020, with a value of $257,472.
Latest Holdings of John S Kovach
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LIXT | Lixte Biotechnology Holdings Inc | 2020-11-30 | 154,018 | 1.67 | 257,472 |
Holding Weightings of John S Kovach
John S Kovach Form 4 Trading Tracker
According to the SEC Form 4 filings, John S Kovach has made a total of 1 transactions in Lixte Biotechnology Holdings Inc (LIXT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lixte Biotechnology Holdings Inc is the acquisition of 2,110 shares on November 30, 2020, which cost John S Kovach around $100,225.
Insider Trading History of John S Kovach
- 1
John S Kovach Trading Performance
GuruFocus tracks the stock performance after each of John S Kovach's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John S Kovach is 7.92%. GuruFocus also compares John S Kovach's trading performance to market benchmark return within the same time period. The performance of stocks bought by John S Kovach within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John S Kovach's insider trading performs compared to the benchmark.
Performance of John S Kovach
John S Kovach Ownership Network
Ownership Network List of John S Kovach
Ownership Network Relation of John S Kovach
John S Kovach Owned Company Details
What does Lixte Biotechnology Holdings Inc do?
Who are the key executives at Lixte Biotechnology Holdings Inc?
John S Kovach is the director & 10 percent owner & Pres. & CFO & Secty of Lixte Biotechnology Holdings Inc. Other key executives at Lixte Biotechnology Holdings Inc include 10 percent owner Eric Forman , 10 percent owner Glenn Krinsky , and 10 percent owner Robert Greenberg .
Lixte Biotechnology Holdings Inc (LIXT) Insider Trades Summary
Over the past 18 months, John S Kovach made no insider transaction in Lixte Biotechnology Holdings Inc (LIXT). Other recent insider transactions involving Lixte Biotechnology Holdings Inc (LIXT) include a net purchase of 20,000 shares made by Rene Bernards , and a net purchase of 10,000 shares made by Van Der Baan Bastiaan Jeroen .
In summary, during the past 3 months, insiders sold 0 shares of Lixte Biotechnology Holdings Inc (LIXT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lixte Biotechnology Holdings Inc (LIXT) were sold and 30,000 shares were bought by its insiders, resulting in a net purchase of 30,000 shares.
Lixte Biotechnology Holdings Inc (LIXT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lixte Biotechnology Holdings Inc Insider Transactions
John S Kovach Mailing Address
Above is the net worth, insider trading, and ownership report for John S Kovach. You might contact John S Kovach via mailing address: 1801 Century Park East #1600, Los Angeles Ca 90067.